AISDTS is a prospective registry study, in which clinical information, examination and imaging data of patients with acute ischemic stroke receiving different treatment strategies were collected, grouped and statistically analyzed, and corresponding clinical prediction models were constructed to explore the role of clinical biological indicators in the occurrence and development of stroke.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To assess the changes of prognosis of stroke patients under different treatment strategies
Timeframe: 3 months, 6 months, 12 months or 24 months
To assess the early neurological changes of ischemic stroke
Timeframe: 7 days or 14 days